VP
venBio Partners’s Apellis Pharmaceuticals APLS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-411,471
| Closed | -$26M | – | 10 |
|
|
2021
Q2 | $26M | Sell |
411,471
-79,000
| -16% | -$4.99M | 3.07% | 6 |
|
|
2021
Q1 | $21M | Hold |
490,471
| – | – | 2% | 6 |
|
|
2020
Q4 | $28.1M | Sell |
490,471
-11,113
| -2% | -$636K | 2.48% | 5 |
|
|
2020
Q3 | $15.1M | Hold |
501,584
| – | – | 2.3% | 6 |
|
|
2020
Q2 | $16.4M | Hold |
501,584
| – | – | 13.62% | 3 |
|
|
2020
Q1 | $13.4M | Sell |
501,584
-498,416
| -50% | -$13.4M | 11.45% | 3 |
|
|
2019
Q4 | $30.6M | Hold |
1,000,000
| – | – | 13.13% | 4 |
|
|
2019
Q3 | $24.1M | Hold |
1,000,000
| – | – | 11.43% | 4 |
|
|
2019
Q2 | $25.3M | Sell |
1,000,000
-526,122
| -34% | -$13.3M | 11.24% | 4 |
|
|
2019
Q1 | $29.8M | Sell |
1,526,122
-263,980
| -15% | -$5.15M | 24.1% | 2 |
|
|
2018
Q4 | $23.6M | Buy |
+1,790,102
| New | +$23.6M | 62.01% | 1 |
|